Relationship between serum estradiol levels and topical estrogen cream used in girls with labial adhesions

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012121611560N1

Enrollment

150

Registered

2013-01-31

Start date

2011-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minor Labial Adhesion. Adhesions of vulva

Interventions

EQUIN conjugated estrogens USP, 0.625 mg/g, Spain, daily, seven days.

Treatment - Drugs

EQUIN conjugated estrogens USP, 0.625 mg/g, Spain, daily, seven days

Eligibility

Sex/Gender

Female

Age

No minimum to 9 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: age between 3 months and 8 years; no puberty ; labia adhesion >25%; no voluvagenitis. Exclusion Criteria : no use of Drug; no follow up; adverse drug reaction.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Release of adhesion. Timepoint: 7 days. Method of measurement: Clinical Examination.	—

Secondary

Measure	Time frame
No urinery track infection. Timepoint: 3 month. Method of measurement: clinical Examination; history.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Baranak Safaian

Gorgan University of Medical Sciences

safaian_baranak@yahoo.com+98 21 5542 7642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026